Daniel Domingo-Lopez

Dr. Daniel Domingo-Lopez

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 June 2021 in Advanced Science
Verified
Journal Article
Open access
PDF file
Debkalpa GoswamiDebkalpa Goswami
Debkalpa Goswami
DDDaniel Domingo-Lopez
Daniel Domingo-Lopez
NWNiamh A. Ward
Niamh A. Ward
JMJeffrey R. Millman
Jeffrey R. Millman
GDGarry P Duffy
Garry P Duffy
EREllen Roche
Ellen Roche
Stem cell derived insulin producing cells or islets have shown promise in reversing Type 1 Diabetes (T1D), yet successful transplantation currently necessitates long‐term modulation with immunosuppressant drugs. An alternative approach to avoiding this immune response is to utilize an islet macroencapsulation device, where islets are incorporated into a selectively permeable membrane that can protect the transplanted cells from acute host response, whilst enabling delivery of insulin. These macroencapsulation systems have to meet a number of stringent and challenging design criteria in order to achieve the ultimate goal of reversing T1D. In this progress report, the design considerations and functional requirements of macroencapsulation systems are reviewed, specifically for stem‐cell derived islets (SC‐islets), highlighting distinct design parameters. Additionally, a perspective on the future for macroencapsulation systems is given, and how incorporating continuous sensing and closed‐loop feedback can be transformative in advancing toward an autonomous biohybrid artificial pancreas.

3 August 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
WWWilliam Whyte
William Whyte
Debkalpa GoswamiDebkalpa Goswami
Debkalpa Goswami
SWSophie X. Wang
Sophie X. Wang
YFYiling Fan
Yiling Fan
NWNiamh A. Ward
Niamh A. Ward
EREllen Roche
Ellen Roche
Fibrous capsule (FC) formation, secondary to the foreign body response (FBR), impedes molecular transport and is detrimental to the long-term efficacy of implantable drug delivery devices, especially when tunable, temporal control is necessary. We report the development of an implantable mechanotherapeutic drug delivery platform to mitigate and overcome this host immune response using two distinct, yet synergistic soft robotic strategies. Firstly, daily intermittent actuation (cycling at 1 Hz for 5 minutes every 12 hours) preserves long-term, rapid delivery of a model drug (insulin) over 8 weeks of implantation, by mediating local immunomodulation of the cellular FBR and inducing multiphasic temporal FC changes. Secondly, actuation-mediated rapid release of therapy can enhance mass transport and therapeutic effect with tunable, temporal control. In a step towards clinical translation, we utilise a minimally invasive percutaneous approach to implant a scaled-up device in a human cadaveric model. Our soft actuatable platform has potential clinical utility for a variety of indications where transport is affected by fibrosis, such as the management of type 1 diabetes.

30 September 2022 in Advanced Materials Technologies
Verified
Journal Article
Open access
DDDaniel Domingo-Lopez
Daniel Domingo-Lopez
RLRuth E. Levey
Ruth E. Levey
BBBenjamin Brennan
Benjamin Brennan
OCOliver Carroll
Oliver Carroll
SGSarah E. Gale
Sarah E. Gale
GDGarry P. Duffy
Garry P. Duffy
Cell transplantation aims to regenerate damaged tissues and cure currently incurable diseases, such as Type 1 diabetes. Post‐transplantation cell survival is highly limited by the lack of suitable support matrix (anoikis) and insufficient oxygen supply (hypoxia), which is aggravated when using macroencapsulation devices. Graft failure can be overcome by encapsulation in extracellular matrix (ECM)‐based hydrogels with high oxygen capacity. Estimation of the oxygen durability in these systems is critical for the design of hydrogel loaded macroencapsulation devices aimed to increase graft survival. In this study, a novel hyaluronic acid/perfluorocarbon biomaterial (Oxygel) is formulated, oxygenated, and characterized. Oxygel exhibits shear thinning and self‐healing properties while it can carry high oxygen payloads and slowly release them for 90 h, exhibiting a 14.5 times smaller oxygen diffusivity than PBS. In parallel, a model able to predict the oxygen durability within Oxygel upon cell encapsulation is developed and experimentally validated in vitro. Correlations between model estimations and experimental results are found, demonstrating the validity of the model to analyze oxygen durability. The application of this mathematical model to oxygenated cell scaffolds (such as Oxygel) holds great promise to improve cell transplantation success.

31 December 2025 in Bioengineering
Verified
Journal Article
Open access
PDF file
Daniel BrandhorstDaniel Brandhorst
Daniel Brandhorst
HBHeide Brandhorst
Heide Brandhorst
DDDaniel Domingo-Lopez
Daniel Domingo-Lopez
EOEoin O'Cearbhaill
Eoin O'Cearbhaill
FCFergal B. Coulter
Fergal B. Coulter
PJPaul R.v. Johnson
Paul R.v. Johnson
Islet encapsulation has the potential to enable transplantation without requirement for life-long immunosuppression. The period between implantation and revascularisation is most harmful for encapsulated islets as they receive nutrients and oxygen exclusively via diffusion. This critical time gap must be bridged with a temporary oxygen supply to prevent inflammation and apoptosis. Hence, we compared the efficiency of individual components of an oxygen-delivering matrix (hyaluronic acid (HA); HA + perfluorodecalin nanoemulsion; HA + perfluorodecalin nanoemulsion + oxygen) to provide a substitute for the extracellular matrix and to facilitate human islet survival. The islets were loaded into silicone-based macroencapsulation devices with multi-scale porous membranes designed to optimise revascularisation. Four to five days of normoxic culture revealed that non-oxygen-charged nanoemulsion prevented islet disintegration but did not reduce necrosis or apoptosis. Oxygen supply decreased the generation of reactive oxygen species and chemokines, thereby increasing islet yield. Stimulated insulin secretion of encapsulated islets was marginal and severely delayed. Islets incubated in oxygen-precharged nanoemulsion were characterised by the highest stimulation index. These data suggest that islet survival in macroencapsulation devices can be optimised with a multi-functional matrix providing mechanical support and temporary oxygen supply to reduce the production of pro-inflammatory mediators. Suitable oxygen delivery systems with an extended life span must identified before in vivo experiments can be undertaken.

20 August 2026 in Electrochimica Acta
Verified
Journal Article
Open access
KJKavita Jayakumar
Kavita Jayakumar
MFMihai-Cristian Fera
Mihai-Cristian Fera
PPP.YEray Pernia-Blazquez
P.YEray Pernia-Blazquez
DDDaniel Domingo-Lopez
Daniel Domingo-Lopez
ALAntonio De Lacey
Antonio De Lacey
MPMarcos Pita
Marcos Pita